Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.72
-$0.043-5.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.42M | 1.60M | 1.60M | 2.55M | 2.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.54M | 6.28M | 8.46M | 8.13M | 7.92M |
| Operating Income | -6.54M | -6.28M | -8.46M | -8.13M | -7.92M |
| Income Before Tax | -6.43M | -6.25M | -8.37M | -7.85M | -7.43M |
| Income Tax Expenses | 5.20K | 4.70K | -- | 7.40K | 7.40K |
| Earnings from Continuing Operations | -6.43M | -6.26M | -8.37M | -7.86M | -7.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.43M | -6.26M | -8.37M | -7.86M | -7.43M |
| EBIT | -6.54M | -6.28M | -8.46M | -8.13M | -7.92M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.13 | -0.16 | -0.25 | -0.26 | -0.25 |
| Normalized Basic EPS | -0.08 | -0.10 | -0.15 | -0.16 | -0.16 |
| EPS Diluted | -0.13 | -0.16 | -0.25 | -0.26 | -0.25 |
| Normalized Diluted EPS | -0.08 | -0.10 | -0.15 | -0.16 | -0.16 |
| Average Basic Shares Outstanding | 48.64M | 38.32M | 33.80M | 30.56M | 29.89M |
| Average Diluted Shares Outstanding | 48.64M | 38.32M | 33.80M | 30.56M | 29.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |